- Home
- MDCX vs GROW Comparison
MDCX vs GROW Comparison
Compare MDCX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MDCX | GROW |
|---|---|---|
| Founded | 2008 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 31.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDCX | GROW |
|---|---|---|
| Price | $0.95 | $3.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $23.50 | N/A |
| AVG Volume (30 Days) | ★ 375.5K | 129.8K |
| Earning Date | 03-27-2026 | 11-13-2025 |
| Dividend Yield | N/A | ★ 2.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $8,546,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $2.02 |
| 52 Week High | $8.94 | $3.65 |
Technical Indicators
Market Signals| Indicator | MDCX | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 21.00 | 64.05 |
| Support Level | $1.09 | $2.88 |
| Resistance Level | $1.29 | $3.19 |
| Average True Range (ATR) | 0.12 | 0.22 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 1.17 | 59.76 |
Price Performance
Historical ComparisonAbout MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.